CytomX Therapeutics Inc (CTMX) is near the top of its industry group according to InvestorsObserver. CTMX scores an overall rating of 68. This means it scores above 68% of the shares. CytomX Therapeutics Inc. ranks 82 in the biotechnology industry. Biotechnology is number 34 out of 148 industries.
What do these notes mean?
Stock analysis can be difficult. There are tons of numbers and ratios out there, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We categorize most of our scores by percentiles to make it easier for investors to understand. A score of 68 means the stock is more attractive than 68% of stocks. Our proprietary rating system captures technical factors, fundamental analysis and the opinions of Wall Street analysts. This makes InvestorsObserverThe overall rating of is a great way to get started, regardless of your investing style. Scores ranked in percentiles are also easy to understand. A score of 100 is high and a 0 is low. There’s no need to try to remember what’s “good” for a bunch of complicated ratios, just pay attention to the higher numbers.
What’s going on with CytomX Therapeutics Inc stock today?
CytomX Therapeutics Inc (CTMX) stock is trading at $2.61 as of 3:54 p.m. on Wednesday, January 25, down -$0.14, or -5.09% from the previous closing price of $2.75. The stock has traded between $2.56 and $2.74 so far today. Volume today is less active than usual. So far, 1,185,689 shares have been traded with an average volume of 3,971,955 shares. Click here for the full CytomX Therapeutics Inc. stock report.
Stay in the know
Subscribe to our daily morning update newsletter and never miss market news, moves and more.